新肥胖定义对MASLD患者分类及结局的影响
该多国VCTE预后队列纳入12,583例MASLD患者,比较BMI、EASO和Lancet委员会三种肥胖定义。EASO和Lancet定义使20.4%和34.1%的BMI非肥胖患者被新归类为肥胖,但这些新分类组与各自非肥胖组相比肝脏相关事件风险无显著升高,仅腰高比接近0.6时风险才显著增加。
要点
- 新肥胖定义扩大肥胖人群但未改善LRE预测
- 仅腰高比接近0.6时LRE风险显著增加
- BMI定义的肥胖仍与LRE风险升高相关
核心结论
- 新肥胖定义扩大了肥胖人群但未改善对肝脏相关事件的预测能力,仅腰高比接近0.6时风险显著增加。
研究设计与样本
- 多国VCTE预后队列研究,纳入12,583例代谢功能障碍相关脂肪性肝病患者,比较BMI、EASO和Lancet委员会三种肥胖定义。
主要发现
- BMI定义正常体重、超重和肥胖的LRE发生率分别为2.4、3.4和5.2/1000人年。
- 20.4%和34.1%的BMI非肥胖患者分别符合EASO和Lancet肥胖定义。
- 新分类肥胖组与各自非肥胖组相比LRE风险无显著升高(EASO调整sHR 1.15,95%CI 0.64-2.08;Lancet调整sHR 0.75,95%CI 0.42-1.34)。
- 新分类肥胖组LRE发生率分别为2.9(95%CI 1.9-4.3)和2.7(95%CI 1.8-3.9)/1000人年。
- 仅当腰高比接近0.6时LRE风险才显著增加。
临床怎么用
- 在MASLD患者风险评估中,BMI仍是肝脏相关事件预测的有效指标,新肥胖定义暂未显示额外预测价值。
- 腰高比接近0.6可能提示LRE风险增加,可作为进一步评估的参考阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: New obesity definitions beyond body mass index (BMI) have recently been proposed. This study aimed to assess the proportion of obesity under these frameworks and their associations with liver-related events (LREs). APPROACH AND RESULTS: We analyzed data from the multinational vibration-controlled transient elastography (VCTE)-prognosis cohort of 12,583 patients with metabolic dysfunction-associated steatotic liver disease. Obesity was defined using 3 frameworks: BMI alone, the European Association for the Study of Obesity (EASO) criteria (BMI-defined obesity or overweight with waist-to-height ratio ≥0.5 plus comorbidity), and the Lancet Commission criteria (BMI-defined obesity plus ≥1 elevated anthropometric measure, or ≥2 elevated anthropometric measures, or BMI ≥40 kg/m²). LRE incidence per 1000 person-years was 2.4 (95% CI: 1.5-3.7), 3.4 (95% CI: 2.6-4.5), and 5.2 (95% CI: 4.3-6.3) for BMI-defined normal weight, overweight, and obesity. Overall, 20.4% and 34.1% of patients were not classified as obese by BMI but met obesity criteria under the EASO and Lancet definitions. These newly classified obese groups did not have higher LRE risk compared with their nonobese counterparts (adjusted subdistribution HR 1.15 [0.64-2.08] for EASO; 0.75 [0.42-1.34] for Lancet ), with incidence rates of 2.9 (95% CI: 1.9-4.3) and 2.7 (95% CI: 1.8-3.9) per 1000 person-years. LRE risk increased significantly only when the waist-to-height ratio approached 0.6. CONCLUSIONS: New obesity definitions broadened the obesity population but did not improve LRE prediction over BMI alone. Higher waist-based thresholds warrant further evaluation.
引用
- Cai J, Yip TC, Lin H, et al. Implications of new obesity definitions in the classification and outcomes of patients with MASLD. Hepatology. 2026. PMID: 42507833. doi:10.1097/HEP.0000000000001827
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。